"It's a vote of confidence in our health system," Illa said, adding it was the first human trial for a coronavirus vaccine to be approved in Spain. Spain, which has western Europe's highest tally of coronavirus cases, is also working with AstraZeneca via the European Union's vaccine procurement programme to secure sufficient doses. J&J's website says if the latest trials are successful, it will begin final Phase III studies, in which even more volunteers will receive the experimental vaccine. There is so far no approved vaccine, except one authorised in Russia before large-scale trials. The company's potential vaccine uses "viral vectors" to generate immune responses, similar to the approach taken by the University of Oxford and AstraZeneca in their experimental vaccine, as well as China's CanSino.

Source: bd News24 August 28, 2020 11:03 UTC